| UniProt ID | SNX2_MOUSE | |
|---|---|---|
| UniProt AC | Q9CWK8 | |
| Protein Name | Sorting nexin-2 | |
| Gene Name | Snx2 | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 519 | |
| Subcellular Localization |
Early endosome membrane Peripheral membrane protein Cytoplasmic side . Cell projection, lamellipodium. Colocalized with SORT1 to tubular endosomal membrane structures called endosome-to-TGN transport carriers (ETCs) which are budding from early end |
|
| Protein Description | Involved in several stages of intracellular trafficking. Interacts with membranes containing phosphatidylinositol 3-phosphate (PtdIns(3P)) or phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). Acts in part as component of the retromer membrane-deforming SNX-BAR subcomplex. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX-BAR subcomplex functions to deform the donor membrane into a tubular profile called endosome-to-TGN transport carrier (ETC). Can sense membrane curvature and has in vitro vesicle-to-membrane remodeling activity. Required for retrograde endosome-to-TGN transport of TGN38. Promotes KALRN- and RHOG-dependent but retromer-independent membrane remodeling such as lamellipodium formation; the function is dependent on GEF activity of KALRN (By similarity).. | |
| Protein Sequence | MAAEREPPPLGDVKPTDFEELEDGEDLFTSTVSTLESSPSSPEPASLPAEDISANSNGSKPVEVVLDDDREDLFAEATEEVSLDSPERELILSSEPSPAVTPVTPTTLIAPRIESKSISAPVIFDRSRDEIEEEANGDIFDIEIGVSDPEKVGDGMNAYMAYRVTTKTSLSMFSKSEFSVKRRFSDFLGLHSKLASKYLHVGYIVPPAPEKSIVGMTKVKVGKEDSSSTEFVEKRRAALERYLQRTVKHPTLLQDPDLRQFLESSELPRAVNTQALSGAGILRMVNKAADAVNKMTIKMNESDAWFEEKQQQFENLDQQLRKLHASVEALVCHRKELSANTAAFAKSAAMLGNSEDHTALSRALSQLAEVEEKIDQLHQEQAFADFYMFSELLSDYIRLIAAVKGVFDHRMKCWQKWEDAQITLLKKRETEAKMMVANKPDKIQQAKNEIREWEAKVQQGERDFEQISKTIRKEVGRFEKERVKDFKAVIIKYLESLVQTQQQLIKYWEAFLPEAKAIA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 85 | Phosphorylation | TEEVSLDSPERELIL HEECCCCCCCCEEEC | 33.67 | - | |
| 93 | Phosphorylation | PERELILSSEPSPAV CCCEEECCCCCCCCC | 26.17 | 25168779 | |
| 94 | Phosphorylation | ERELILSSEPSPAVT CCEEECCCCCCCCCC | 50.51 | 22942356 | |
| 97 | Phosphorylation | LILSSEPSPAVTPVT EECCCCCCCCCCCCC | 22.80 | 26824392 | |
| 101 | Phosphorylation | SEPSPAVTPVTPTTL CCCCCCCCCCCCCEE | 17.72 | 25521595 | |
| 104 | Phosphorylation | SPAVTPVTPTTLIAP CCCCCCCCCCEEECC | 19.00 | 25521595 | |
| 106 | Phosphorylation | AVTPVTPTTLIAPRI CCCCCCCCEEECCCC | 25.52 | 24723360 | |
| 107 | Phosphorylation | VTPVTPTTLIAPRIE CCCCCCCEEECCCCC | 19.85 | 25521595 | |
| 115 | Phosphorylation | LIAPRIESKSISAPV EECCCCCCCCCCCCE | 29.36 | 24719451 | |
| 116 | Acetylation | IAPRIESKSISAPVI ECCCCCCCCCCCCEE | 38.73 | 23806337 | |
| 116 | Ubiquitination | IAPRIESKSISAPVI ECCCCCCCCCCCCEE | 38.73 | 27667366 | |
| 117 | Phosphorylation | APRIESKSISAPVIF CCCCCCCCCCCCEEE | 30.93 | 25521595 | |
| 119 | Phosphorylation | RIESKSISAPVIFDR CCCCCCCCCCEEEEC | 33.34 | 25521595 | |
| 165 | Phosphorylation | AYMAYRVTTKTSLSM HEEEEEEECCCCHHH | 17.36 | 29472430 | |
| 166 | Phosphorylation | YMAYRVTTKTSLSMF EEEEEEECCCCHHHC | 29.48 | 29472430 | |
| 167 | Ubiquitination | MAYRVTTKTSLSMFS EEEEEECCCCHHHCC | 27.10 | - | |
| 168 | Phosphorylation | AYRVTTKTSLSMFSK EEEEECCCCHHHCCC | 32.57 | 28576409 | |
| 169 | Phosphorylation | YRVTTKTSLSMFSKS EEEECCCCHHHCCCC | 21.72 | 29472430 | |
| 171 | Phosphorylation | VTTKTSLSMFSKSEF EECCCCHHHCCCCCH | 19.97 | 24759943 | |
| 174 | Phosphorylation | KTSLSMFSKSEFSVK CCCHHHCCCCCHHHH | 26.99 | 29472430 | |
| 175 | Acetylation | TSLSMFSKSEFSVKR CCHHHCCCCCHHHHH | 42.62 | 7718691 | |
| 181 | Ubiquitination | SKSEFSVKRRFSDFL CCCCHHHHHHHHHHH | 36.34 | 27667366 | |
| 181 | Acetylation | SKSEFSVKRRFSDFL CCCCHHHHHHHHHHH | 36.34 | 7718701 | |
| 185 | Phosphorylation | FSVKRRFSDFLGLHS HHHHHHHHHHHHHHH | 26.16 | 25521595 | |
| 192 | Phosphorylation | SDFLGLHSKLASKYL HHHHHHHHHHHHHHC | 34.11 | 25266776 | |
| 193 | Ubiquitination | DFLGLHSKLASKYLH HHHHHHHHHHHHHCC | 37.01 | - | |
| 203 | Phosphorylation | SKYLHVGYIVPPAPE HHHCCEEEECCCCCC | 9.54 | - | |
| 212 | Phosphorylation | VPPAPEKSIVGMTKV CCCCCCCCEECEEEE | 22.35 | 25521595 | |
| 218 | Ubiquitination | KSIVGMTKVKVGKED CCEECEEEEEECCCC | 31.03 | - | |
| 220 | Ubiquitination | IVGMTKVKVGKEDSS EECEEEEEECCCCCC | 46.99 | - | |
| 223 | Ubiquitination | MTKVKVGKEDSSSTE EEEEEECCCCCCCHH | 62.43 | - | |
| 226 | Phosphorylation | VKVGKEDSSSTEFVE EEECCCCCCCHHHHH | 27.55 | 26824392 | |
| 227 | Phosphorylation | KVGKEDSSSTEFVEK EECCCCCCCHHHHHH | 54.31 | 18779572 | |
| 228 | Phosphorylation | VGKEDSSSTEFVEKR ECCCCCCCHHHHHHH | 35.59 | 18779572 | |
| 229 | Phosphorylation | GKEDSSSTEFVEKRR CCCCCCCHHHHHHHH | 35.08 | 18779572 | |
| 234 | Succinylation | SSTEFVEKRRAALER CCHHHHHHHHHHHHH | 41.71 | 23954790 | |
| 273 | Phosphorylation | ELPRAVNTQALSGAG CCCCCCCHHHHCHHH | 14.50 | 22324799 | |
| 277 | Phosphorylation | AVNTQALSGAGILRM CCCHHHHCHHHHHHH | 29.61 | 22942356 | |
| 287 | Ubiquitination | GILRMVNKAADAVNK HHHHHHHHHHHHHHH | 33.28 | 27667366 | |
| 309 | Acetylation | SDAWFEEKQQQFENL HHHHHHHHHHHHHCH | 46.32 | 23954790 | |
| 341 | Phosphorylation | RKELSANTAAFAKSA HHHCCHHHHHHHHHH | 21.05 | 20139300 | |
| 346 | Ubiquitination | ANTAAFAKSAAMLGN HHHHHHHHHHHHHCC | 33.89 | - | |
| 354 | Phosphorylation | SAAMLGNSEDHTALS HHHHHCCCHHHHHHH | 42.47 | 29514104 | |
| 365 | Phosphorylation | TALSRALSQLAEVEE HHHHHHHHHHHHHHH | 23.35 | 26824392 | |
| 447 | Malonylation | PDKIQQAKNEIREWE HHHHHHHHHHHHHHH | 51.26 | 26320211 | |
| 468 | Phosphorylation | ERDFEQISKTIRKEV CCCHHHHHHHHHHHH | 24.36 | 21454597 | |
| 469 | Acetylation | RDFEQISKTIRKEVG CCHHHHHHHHHHHHC | 49.99 | - | |
| 487 | Ubiquitination | KERVKDFKAVIIKYL HHHHHHHHHHHHHHH | 52.45 | - | |
| 487 | Acetylation | KERVKDFKAVIIKYL HHHHHHHHHHHHHHH | 52.45 | 23236377 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 104 | T | Phosphorylation | Kinase | MAPK1 | P63085 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SNX2_MOUSE !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SNX2_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of SNX2_MOUSE !! | ||||
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-185, AND MASSSPECTROMETRY. | |
| "Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND MASSSPECTROMETRY. | |